Cardiology
Durable Efficacy and Safety of Percutaneous Transseptal TMVR: Two-Year Outcomes from the ENCIRCLE Trial
The ENCIRCLE trial reports sustained mitral regurgitation reduction, improved functional status, and manageable safety outcomes at 2 years after percutaneous transseptal TMVR using the SAPIEN M3 system in high-risk symptomatic MR patients.
